Oren Hershkovitz

Company: Enlivex

Job title: CEO

Seminars:

Allocetra: Off-The-Shelf, Universal, Macrophage Reprogramming Cell Therapies For Life-Threatening Diseases Including Solid Tumors 2:30 pm

Introducing  Allocetra – a new modality of macrophages reprogramming into their homeostatic state for treatment of unmet medical conditions Presenting significant synergistic anti-cancer combination therapy effect of Allocetra and CAR-T in human cervical cancer mice model Discussing the transition into first in human clinical studies in peritoneal metastasisRead more

day: Day 1 - Track B - Lunch